Please login to the form below

Not currently logged in
Email:
Password:

AAT Research appoints Wolfgang Storf to lead expansion

He brings experience as Sandoz's former South Africa CEO

AAT Research Wolfgang StorfMalta-based group AAT Research has appointed Wolfgang Storf as its new chief executive officer.

Storf joins from MS Pharma Group, where he served as chief strategy officer, and has previously served as CEO of Novartis' Sandoz division in South Africa and held senior management positions with Apotex and Johnson & Johnson.

In his new role he will be tasked with consolidating AAT's internationalisation strategy and leading its expansion into new markets.

Storf said: “I am delighted to take over as CEO at this important stage of AAT's growth, and I'm looking forward to working with the executive team and the board to help the company realise its full potential, enter new markets and establish our products as leading therapies and services for patients and medical professionals respectively.”

His appointment at AAT, which designs and develops medical solutions in neuroscience, will see founder and former CEO Dr Adrian Attard Trevsisan become to the group's chief scientific officer.

Dr Attard Trevisan said: “We have come a long way from a small one-room setup. As the company continues to grow and increase its international footprint, we felt the need to bring in a senior executive who has extensive international experience in the pharmaceutical and medical industries.

He added that his own focus would now be on research, innovation and product development.

14th April 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....